Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues

RHB Benedict, MP Amato, J DeLuca… - The Lancet …, 2020 - thelancet.com
Multiple sclerosis is a chronic, demyelinating disease of the CNS. Cognitive impairment is a
sometimes neglected, yet common, sign and symptom with a profound effect on instrumental …

Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis

C Granziera, J Wuerfel, F Barkhof, M Calabrese… - Brain, 2021 - academic.oup.com
Quantitative MRI provides biophysical measures of the microstructural integrity of the CNS,
which can be compared across CNS regions, patients, and centres. In patients with multiple …

Identifying the distinct cognitive phenotypes in multiple sclerosis

E De Meo, E Portaccio, A Giorgio, L Ruano… - JAMA …, 2021 - jamanetwork.com
Importance Cognitive impairment is a common and disabling feature of multiple sclerosis
(MS), but a precise characterization of cognitive phenotypes in patients with MS is lacking …

Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis

M Margoni, P Preziosa, MA Rocca, M Filippi - Translational Psychiatry, 2023 - nature.com
Neuropsychiatric abnormalities may be broadly divided in two categories: disorders of
mood, affect, and behavior and abnormalities affecting cognition. Among these conditions …

Mind the gap: from neurons to networks to outcomes in multiple sclerosis

DT Chard, AAS Alahmadi, B Audoin… - Nature Reviews …, 2021 - nature.com
MRI studies have provided valuable insights into the structure and function of neural
networks, particularly in health and in classical neurodegenerative conditions such as …

Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration

L van Olst, C Rodriguez-Mogeda, C Picon, S Kiljan… - Acta …, 2021 - Springer
Meningeal inflammation strongly associates with demyelination and neuronal loss in the
underlying cortex of progressive MS patients, thereby contributing significantly to clinical …

Central nervous system demyelinating diseases: glial cells at the hub of pathology

VG Coutinho Costa, SES Araújo… - Frontiers in …, 2023 - frontiersin.org
Inflammatory demyelinating diseases (IDDs) are among the main causes of inflammatory
and neurodegenerative injury of the central nervous system (CNS) in young adult patients …

Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study

D Jakimovski, R Zivadinov… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Background: A limited number of studies investigated associations between serum
neurofilament light chain (sNfL) and cognition in persons with multiple sclerosis (PwMS) …

Relationship between white matter lesions and gray matter atrophy in multiple sclerosis: a systematic review

IA Lie, MM Weeda, RM Mattiesing, MAE Mol… - Neurology, 2022 - AAN Enterprises
Background and Objectives There is currently no consensus about the extent of gray matter
(GM) atrophy that can be attributed to secondary changes after white matter (WM) lesions or …

[HTML][HTML] Role of artificial intelligence in MS clinical practice

R Bonacchi, M Filippi, MA Rocca - NeuroImage: Clinical, 2022 - Elsevier
Abstract Machine learning (ML) and its subset, deep learning (DL), are branches of artificial
intelligence (AI) showing promising findings in the medical field, especially when applied to …